The Office of Inspector General reported in March that the clinic often complied with CMS rules for intravitreal injections of Eylea and Lucentis, but did not always meet requirements when billing for other services on the same day, such as anesthesia injections. Out of 627 services and drugs provided in a 100-day period in 2018, 301 did not meet requirements.
The clinic did not separately bill for 195 services, and 106 services and drugs were deemed not reasonable and necessary, according to the inspector general’s report.
The clinic didn’t have appropriate policies and procedures for accurate service and drug billing because its medical director was unaware of Medicare requirements, the report states. The clinic agreed to refund Medicare $398,625 in overpayments and implement new policies, according to the report.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
